Product Information
FOSAPREPITANT 150 MG VIAL is a generic product labeled by Eugia US LLC, priced at $38.5080 per EA under NDC 55150029901. Its NADAC has been published 35 times since Aug 21, 2024.
Strength
150 mg/5mL
Manufacturer
Eugia US LLCNDC
55150029901
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Last Updated
8/21/2024
Active Ingredients
FOSAPREPITANT DIMEGLUMINEApproval Type
Generic (ANDA)
FDA Application
ANDA210625On Market Since
1/12/2021
Pharmacological Classes
Price Statistics
The NADAC for FOSAPREPITANT 150 MG VIAL has been published 35 times since Aug 21, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $38.5080 per EA |
|---|---|
| All-time high | $38.5080 (Apr 16, 2025) |
| All-time low | $38.5080 (Aug 21, 2024) |
| Median price | $38.5080 |
| Average price | $38.5080 |
| Largest weekly change | 0.0% (Aug 28, 2024) |
| Weeks tracked | 35 |
| Tracking since | Aug 21, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FOSAPREPITANT 150 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for FOSAPREPITANT 150 MG VIAL, manufactured by Eugia US LLC, is $38.5080 per EA (NDC 55150029901), effective Apr 16, 2025.
How has the price of FOSAPREPITANT 150 MG VIAL changed over time?
Over the history we have for it, the NADAC for FOSAPREPITANT 150 MG VIAL has held within roughly two percent of its current level. It has been tracked across 35 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for FOSAPREPITANT 150 MG VIAL?
Since Aug 21, 2024, the NADAC for FOSAPREPITANT 150 MG VIAL has ranged from a low of $38.5080 (Aug 21, 2024) to a high of $38.5080 (Apr 16, 2025), with a median of $38.5080 per EA.
Are there cheaper alternatives to FOSAPREPITANT 150 MG VIAL?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as FOSAPREPITANT 150 MG VIAL, but none are currently priced below it.
Who manufactures FOSAPREPITANT 150 MG VIAL?
FOSAPREPITANT 150 MG VIAL (NDC 55150029901) is labeled by Eugia US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification